Burton I Korelitz
Overview
Explore the profile of Burton I Korelitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
379
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Segmental sigmoid polyposis as a colonoscopic indicator of an ileosigmoid fistula in Crohn's ileitis
Korelitz B, Taunk R, Kesar V
J Crohns Colitis
. 2015 Jan;
9(4):339-41.
PMID: 25634034
Background And Aims: Ileosigmoid fistulas (ISFs) are frequently undiagnosed prior to surgery. This study was designed to describe a polyp or cluster of polyps limited to the sigmoid colon as...
13.
Mammen A, Korelitz B
J Clin Gastroenterol
. 2014 Sep;
49(3):257-8.
PMID: 25264690
No abstract available.
14.
Korelitz B, Sultan K, Kothari M, Arapos L, Schneider J, Panagopoulos G
World J Gastroenterol
. 2014 May;
20(17):4980-6.
PMID: 24803809
Aim: To search for the answer in extensive ulcerative colitis as to whether histological inflammation persisting despite endoscopic mucosal healing serves to increase the risk of colon cancer (CC) or...
15.
Korelitz B, Present D
J Crohns Colitis
. 2014 Jan;
8(8):735-8.
PMID: 24462321
Two large studies concluded that AZA started early after diagnosis of Crohn's disease have no late maintenance value. This is contrary to previous studies on 6MP for Crohn's disease and...
16.
Korelitz B
World J Gastroenterol
. 2013 May;
19(20):2979-84.
PMID: 23716977
Arbitrarily, modern day treatment of inflammatory bowel disease begins with the introduction of immunosuppressives for ulcerative colitis. Clinical improvement with sulfasalazine had been meaningful but modest. Treatment with adrenocorticotropic hormone...
17.
Is treatment with 6-mercaptopurine for colitis associated with the development of colorectal cancer?
Satchi M, Korelitz B, Panagopoulos G, Bratcher J, Yu C, Atallah-Vinograd J, et al.
Inflamm Bowel Dis
. 2013 Feb;
19(4):785-8.
PMID: 23392347
Background: Patients with ulcerative colitis and Crohn's colitis have an increased risk of colon cancer influenced by the duration, extent, and severity of disease. Surveillance colonoscopy serves to detect cancer...
18.
Vinod J, Vadada D, Korelitz B, Sonpal N, Panagopoulos G, Baiocco P
J Clin Gastroenterol
. 2012 May;
46(6):527-9.
PMID: 22565604
No abstract available.
19.
Sultan K, Korelitz B, Present D, Katz S, Sunday S, Shapira I
Inflamm Bowel Dis
. 2012 Jan;
18(10):1855-8.
PMID: 22241664
Background: 6-Mercaptopurine (6-MP) and azathioprine (AZA) are effective for induction and maintenance therapy of Crohn's disease (CD) and ulcerative colitis (UC). There is an increased risk of lymphoma in patients...
20.
Peter I, Mitchell A, Ozelius L, Erazo M, Hu J, Doheny D, et al.
BMC Med Genet
. 2011 May;
12:63.
PMID: 21548950
Background: Crohn's disease (CD) has the highest prevalence among individuals of Ashkenazi Jewish (AJ) descent compared to non-Jewish Caucasian populations (NJ). We evaluated a set of well-established CD-susceptibility variants to...